These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10650130)

  • 1. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats.
    Zhang Y; Raap DK; Garcia F; Serres F; Ma Q; Battaglia G; Van de Kar LD
    Brain Res; 2000 Feb; 855(1):58-66. PubMed ID: 10650130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin.
    Landry M; Frasier M; Chen Z; Van De Kar LD; Zhang Y; Garcia F; Battaglia G
    Synapse; 2005 Nov; 58(2):102-9. PubMed ID: 16088947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van de Kar LD
    Am J Physiol Regul Integr Comp Physiol; 2004 Feb; 286(2):R390-7. PubMed ID: 14604841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.
    Berton O; Durand M; Aguerre S; Mormède P; Chaouloff F
    Neuroscience; 1999; 92(1):327-41. PubMed ID: 10392854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
    Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
    J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S; Graf M; Anheuer ZE; Bagdy G
    Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear.
    Rittenhouse PA; Bakkum EA; O'Connor PA; Carnes M; Bethea CL; van de Kar LD
    Brain Res; 1992 May; 580(1-2):205-14. PubMed ID: 1354556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
    Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
    J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol accelerates the effects of fluoxetine on serotonin 1A receptor signaling.
    Li Q; Sullivan NR; McAllister CE; Van de Kar LD; Muma NA
    Psychoneuroendocrinology; 2013 Jul; 38(7):1145-57. PubMed ID: 23219224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of 5-hydroxytryptamine(1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine(1A) receptors in hypothalamus.
    Serres F; Muma NA; Raap DK; Garcia F; Battaglia G; Van de Kar LD
    J Pharmacol Exp Ther; 2000 Jul; 294(1):296-301. PubMed ID: 10871325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
    Li Q; Muma NA; van de Kar LD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    Li Q; Murakami I; Stall S; Levy AD; Brownfield MS; Nichols DE; Van de Kar LD
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1261-7. PubMed ID: 8968349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors and neuroendocrine function.
    Raap DK; Van de Kar LD
    Life Sci; 1999; 65(12):1217-35. PubMed ID: 10503938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
    Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
    Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.
    Burghardt NS; Bush DE; McEwen BS; LeDoux JE
    Biol Psychiatry; 2007 Nov; 62(10):1111-8. PubMed ID: 17524369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.